Analysis of the expression of angiotensin II type 1 receptor and VEGF in endometrial adenocarcinoma with different clinicopathological characteristics

Tumor Biology

Volumn 33, Issue 3, 2012, Pages 767-774

  Piastowska Ciesielska, Agnieszka Wanda ^a   Płuciennik, Elibieta ^a   Wójcik Krowiranda, Katarzyna ^a   Bieñkiewicz, Andrzej ^a   Bednarek, Andrzej ^a   Ochêdalski, Tomasz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Angiotensin receptor; Clinicopathological characteristics; Endometrial adenocarcinoma; Oestrogen receptor

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN A;

ADULT; ARTICLE; AT1 R GENE; AT2 R GENE; CANCER GRADING; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIUM CARCINOMA; ER ALPHA GENE; FEMALE; GENE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VEGF GENE; ADENOCARCINOMA; AGED; ENDOMETRIUM TUMOR; GENE EXPRESSION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION; HUMANS; MIDDLE AGED; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84863610800     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-011-0292-0     Document Type: Article

References (24)

1. Grosman-Dziewiszek P, Dziegiel P, Zabel M. Disturbance of gene expression in endometrial cancer as therapy aim. Ginekol Pol. 2011;82:276-80.
2. Shibata K, Kikkawa F, Mizokami Y, Kajiyama H, Ino K, Nomura S, Mizutani S. Possible involvement of adipocyte-derived leucine aminopeptidase via angiotensin II in endometrial carcinoma. Tumour Biol. 2005;26:9-16.
3. Lam KY, Leung PS. Regulation and expression of a renin-angiotensin system in human pancreas and pancreatic endocrine tumours. Eur J Endocrinol. 2002;146:567-72.
4. Uemura H, Ishiguro H, Nagashima Y, Sasaki T, Nakaigawa N, Hasumi H, Kato S, Kubota Y. Antiproliferative activity of angiotensin II receptor blocker through cross-talk between stromal and epithelial prostate cancer cells. Mol Cancer Ther. 2005;4:1699-709.
5. Ager EI, Neo J, Christophi C. The renin-angiotensin system and malignancy. Carcinogenesis. 2008;29:1675-84.
6. Day RT, Cavaglieri RC, Tabatabaimir H, Mantravadi V, Lee MJ, Barnes JL, Kasinath BS, Feliers D. Acute hyperglycemia rapidly stimulates VEGF mRNA translation in the kidney. Role of angiotensin type 2 receptor (AT2). Cell Signal. 2010;22:1849-57.
7. Hsueh WA. Renin in the female reproductive system. Cardiovasc Drugs Ther. 1988;2:473-7.
8. Mitchell MD, Edwin SS, Pollard JK, Trautman MS. Renin stimulates decidual prostaglandin production via a novel mechanism that is independent of angiotensin II formation. Placenta. 1996;17:299-305.
9. Watanabe Y, Shibata K, Kikkawa F, Kajiyama H, Ino K, Hattori A, Tsujimoto M, Mizutani S. Adipocyte-derived leucine aminopeptidase suppresses angiogenesis in human endometrial carcinoma via renin-angiotensin system. Clin Cancer Res. 2003;9:6497-503.
10. Giatromanolaki A, Sivridis E, Brekken R, Thorpe PE, Anastasiadis P, Gatter KC, Harris AL, Koukourakis MI. The angiogenic "vascular endothelial growth factor/flk-1 (KDR) receptor" pathway in patients with endometrial carcinoma: prognostic and therapeutic implications. Cancer. 2001;92:2569-77.
11. Taylor SE, Patel II, Singh PB, Nicholson CM, Stringfellow HF, Gopala Krishna RK, Matanhelia SS, Martin-Hirsch PL, Martin FL. Elevated oestrogen receptor splice variant ERalphaDelta5 expression in tumour-adjacent hormone-responsive tissue. Int J Environ Res Publ Health. 2010;7:3871-89.
12. Sivridis E, Giatromanolaki A, Koukourakis M, Anastasiadis P. Endometrial carcinoma: association of steroid hormone receptor expression with low angiogenesis and bcl-2 expression. Virchows Arch. 2001;438:470-7.
13. Ryan AJ, Susil B, Jobling TW, Oehler MK. Endometrial cancer. Cell Tissue Res. 2005;322:53-61.
14. Vandesompele J, De PK, Pattyn F, Poppe B, Van RN, De PA, Speleman F. Accurate normalization of real-time quantitative RTTumor PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:RESEARCH0034.
15. de Kok JB, Roelofs RW, Giesendorf BA, Pennings JL, Waas ET, Feuth T, Swinkels DW, Span PN. Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab Invest. 2005;85:154-9.
16. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002;30:e36.
17. Neo JH, Ager EI, Angus PW, Zhu J, Herath CB, Christophi C. Changes in the renin angiotensin system during the development of colorectal cancer liver metastases. BMC Cancer. 2010;10:134.
18. Schauser KH, Nielsen AH, Dantzer V, Poulsen K. Angiotensinconverting enzyme activity in the bovine uteroplacental unit changes in relation to the cycle and pregnancy. Placenta. 2001;22:852-62.
19. Ino K, Shibata K, Yamamoto E, Kajiyama H, Nawa A, Mabuchi Y, Yagi S, Minami S, Kikkawa F. 2011 Role of the renin-angiotensin system in gynecologic cancers. Curr Cancer Drug Targets 11(4):405-11
20. Tahmasebi M, Barker S, Puddefoot JR, Vinson GP. Localisation of renin-angiotensin system (RAS) components in breast. Br J Cancer. 2006;95:67-74.
21. Lau ST, Leung PS (2011). Role of the RAS in pancreatic cancer. Curr Cancer Drug Targets 11(4):412-20
22. Koh SL, Ager EI, Christophi C. Liver regeneration and tumour stimulation: implications of the renin-angiotensin system. Liver Int. 2010;30:1414-26.
23. Bai X, Mi R. Expression of VEGF, bFGF and ER in endometrial carcinoma. Zhonghua Zhong Liu Za Zhi. 2001;23:211-3.
24. Yasue A, Hasegawa K, Udagawa Y (2011). Effects of tamoxifen on the endometrium and its mechanism of carcinogenicity. Hum Cell 24(2):65-73